173 related articles for article (PubMed ID: 16381633)
1. [The promoter activity of the DNA sequence corresponding to HCV 5'UTR in HepG2].
Chen WX; Zhang J; Huang Y; Zhang J; Tang N; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):897-9. PubMed ID: 16381633
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
[TBL] [Abstract][Full Text] [Related]
3. [Effect of short interfering RNAs on hepatitis C Virus 5' untranslated region expression].
Chen ZJ; Zhang LH; Li W; Liu X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):319-21. PubMed ID: 18322589
[TBL] [Abstract][Full Text] [Related]
4. Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions.
Pontrelli L; Sidiropoulos KG; Adeli K
Biochemistry; 2004 Jun; 43(21):6734-44. PubMed ID: 15157107
[TBL] [Abstract][Full Text] [Related]
5. Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells.
Zhang JJ; Huang AL; Shi XL; Zhang XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):5-9. PubMed ID: 16468630
[TBL] [Abstract][Full Text] [Related]
6. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
[TBL] [Abstract][Full Text] [Related]
7. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
Signori E; Bagni C; Papa S; Primerano B; Rinaldi M; Amaldi F; Fazio VM
Oncogene; 2001 Jul; 20(33):4596-600. PubMed ID: 11494157
[TBL] [Abstract][Full Text] [Related]
8. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
[TBL] [Abstract][Full Text] [Related]
9. Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.
Gallegos-Orozco JF; Arenas JI; Vargas HE; Kibler KV; Wilkinson JK; Nowicki M; Radkowski M; Nasseri J; Rakela J; Laskus T
J Viral Hepat; 2006 Jul; 13(7):489-98. PubMed ID: 16792543
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis C virus 5' untranslated region gene amplified by rapid amplification of cDNA ends and its secondary structure.
Qin ZX; Cong X; Jiang D; Ha MH; Chen HS; Wei L
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):368-72. PubMed ID: 14607708
[TBL] [Abstract][Full Text] [Related]
11. Impact of HIV on genomic variability in the 5'UTR of HCV in Indian patients with HCV/HIV co-infection.
Chaudhary A; Kukreti H; Pasha ST; Gupta S; Kumari M; Khare S; Lal S; Rai A
Intervirology; 2008; 51(4):224-9. PubMed ID: 18781077
[TBL] [Abstract][Full Text] [Related]
12. Translational control of apolipoprotein B mRNA via insulin and the protein kinase C signaling cascades: evidence for modulation of RNA-protein interactions at the 5'UTR.
Sidiropoulos KG; Zastepa A; Adeli K
Arch Biochem Biophys; 2007 Mar; 459(1):10-9. PubMed ID: 17288985
[TBL] [Abstract][Full Text] [Related]
13. Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse model.
Takeda Y; Okoshi S; Suzuki K; Yano M; Gangemi JD; Jay G; Asakura H; Aoyagi Y
J Viral Hepat; 2004 Jan; 11(1):33-44. PubMed ID: 14738556
[TBL] [Abstract][Full Text] [Related]
14. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR].
Wang XH; Wang SQ; Guan W; Mao BZ
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227
[TBL] [Abstract][Full Text] [Related]
15. Sequence variability of the 5' UTR in isolates of hepatitis C virus in China.
Chen YD; Liu MY; Yu WL; Li JQ; Peng M; Dai Q; Wu J; Liu X; Zhou ZQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):541-52. PubMed ID: 14607684
[TBL] [Abstract][Full Text] [Related]
16. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
17. Translation efficiencies of the 5'-untranslated region of genotypes 1a and 3a in hepatitis C infected patients.
Motazakker M; Preikschat P; Elliott J; Smith CA; Mills PR; Oien K; Spence E; Elliott RM; McCruden EA
J Med Virol; 2007 Mar; 79(3):259-69. PubMed ID: 17245719
[TBL] [Abstract][Full Text] [Related]
18. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
19. [Cell-specific roles of domains I and II of HCV 5'untranslated region in the translation initiation activity].
Huang X; Liu L; Cui G; Liu X; Liu M; Ma Q; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1826-9. PubMed ID: 25537912
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hepatitis C virus subtyping by ns5b sequencing with 5'utr based methods.
Pagani E; Huemer HP; Pasquetto V; Cemin C; Molon L; Rossi P; Larcher C
Minerva Med; 2012 Aug; 103(4):293-7. PubMed ID: 22805621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
